Johnson & Johnson operates two core business divisions - Innovative Medicine and MedTech - serving the global healthcare sector. Founded in 1886 and headquartered in the United States, the company employs over 135,000 people worldwide and has maintained a position among the top three pharmaceutical companies globally for more than a decade. Under CEO Joaquin Duato, the organization focuses on developing pharmaceuticals, medical devices, and surgical technologies across eight primary healthcare domains: oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision care.
The MedTech division develops and manufactures medical devices and surgical technologies, representing one of the company's two core operational areas. This division's work encompasses instrumentation, robotics integration points, and surgical systems that interface with clinical workflows. The hardware and software systems developed here must meet stringent regulatory requirements while operating reliably in demanding clinical environments. Engineers working on these systems address challenges in precision mechanics, sensor integration, real-time control systems, and human-machine interfaces where safety constraints and edge case handling are critical.
The company's technical approach emphasizes science-based innovation with a focus on solving complex healthcare challenges through hardware-software integration. With products reaching billions of people daily, the engineering work involves scaling solutions across diverse regulatory environments and clinical settings worldwide. The organization has operated under its guiding principles document, "Our Credo," for over a century, providing organizational stability while the company pursues development in areas including advanced surgical technologies and medical device systems that require multi-disciplinary engineering expertise.
